Synuclein Nitrase Inhibitor (Nitrase Therapeutics)

N/A

Report date: 2025/08/22 17:57:37
NME

Base Information

Drug NameSynuclein Nitrase Inhibitor (Nitrase Therapeutics)
Drug Alias NameNDC-0524
ClassificationSmall molecules
Mechanisms of ActionAnti-Synuclein alpha
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNitrase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNitrase Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A